Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 381 of 6351
-
Could a stronger first dose of targeted radiation beat back advanced prostate cancer?
Disease control Not yet recruitingThis phase I trial studies the safety, side effects, and treatment cycle 1 best dose of Lu-177-PSMA-617 in patients with prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castration-resistant) and has spread from wh…
Phase 1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gene therapy for rare genetic syndrome moves to Long-Term safety check
Disease control By invitation onlyThis is a long-term follow-up study of participants in the RB001-101 gene replacement therapy clinical trial for Children With SHANK3-related Phelan-McDermid Syndrome (PMS). Participants will roll over from the parent study into this long-term study for continuous safety monitori…
Phase 1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
A tailored plan to prevent bathroom falls in vulnerable adults: will it work?
Prevention Not yet recruitingToileting-related falls may result from a combination of urinary symptoms, impaired gait and balance, reduced muscle strength, cognitive or emotional problems, and unsafe environmental conditions. Older adults and people with disabilities may be especially vulnerable because they…
Sponsor: Qing Yuan • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Can a new eye drop soothe severe dry eye?
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial, enrolling 842 subjects with moderate to severe dry eye, who will be randomized at a 1:1 ratio to receive either 1% OT202 ophthalmic solution or vehicle control. The trial consists of scr…
Phase 3 • Sponsor: Ocumension Therapeutics (Suzhou) Co., Ltd • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Bone scans may reveal how breast cancer subtypes spread
Knowledge-focused Not yet recruitingThe goal of this observational study is to evaluate the association between different molecular subtypes of breast cancer and their specific patterns of skeletal metastases on Technetium-99m MDP bone scintigraphy. The study will include adult male and female patients aged 18 to …
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
New scoring tool aims to reverse type 2 diabetes with personalized plans
Disease control By invitation onlyThis study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each individual patient. Instead of treating all diabetic patients the same way, the SMS classifies patients into one of seve…
Sponsor: Salah Snouda • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Jaw-Widening device may ease sleep apnea without surgery
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether miniscrew-assisted rapid palatal expansion (MARPE) can improve obstructive sleep apnea (OSA) in late adolescents and adults aged 16 to 60 years. The main questions it aims to answer are: 1. Does MARPE improve sleep apnea severi…
Sponsor: University of Malaya • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can stem cell exosomes repair the peritoneum in dialysis patients?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a single intraperitoneal infusion of mesenchymal stem cell-derived exosomes (MSC-Exos) is safe and tolerable in adults with peritoneal dialysis-related peritoneal failure. It will also explore whether MSC-Exos might improve how well …
Phase 1 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a Triple-Drug cocktail turn inoperable liver cancer into a surgical target?
Disease control Not yet recruitingThis study is a single-center, exploratory clinical trial. Eligible patients with liver cancer, after signing the informed consent form, will be screened and enrolled. They will receive a 3-cycle conversion treatment with Envafolimab combined with Suvemcitug and HAIC. During the …
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a new injection slow stomach emptying to curb obesity?
Disease control Recruiting nowThe main purpose of this study is to find out how significantly Eloralintide slows stomach emptying in participants who are overweight or obese. For each participant, the study will last approximately 21 weeks and will include 2 overnight stays in the clinical research unit (CRU)…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Your gut bacteria might hold the key to lung cancer treatment
Knowledge-focused Not yet recruitingLocally advanced lung cancer (LALC) has poor prognosis despite multimodal therapies. Neoadjuvant chemoimmunotherapy is now standard for resectable stage II-IIIB NSCLC, but patient responses vary. The gut microbiota, a key immune regulator, has been linked to immunotherapy efficac…
Sponsor: Guangdong Provincial People's Hospital • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Two biopsy methods together may spare some breast cancer patients a bigger surgery
Diagnosis Not yet recruitingThis prospective observational diagnostic study aims to evaluate the feasibility of using sentinel lymph node biopsy combined with wire localized lymph node biopsy (SLNB+WLNB) to identify breast cancer patients with 1-2 sonographically abnormal axillary lymph nodes who may safely…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Magnetic heat zaps infection in knee implants without removal
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the Sola2 AMF Knee System, when added to surgery and antibiotic treatment, can safely improve outcomes, knee function, and quality of life in adults with knee implant infection. The main questions this study aims to answer are:…
Sponsor: Solenic Medical, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for head and neck cancer: which drug works best with radiation?
Disease control Recruiting nowThis phase III trial compares cetuxumab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients with head and neck cancer who are unable to receive cisplatin. Cetuximab is in a class of medications called monoclonal an…
Phase 3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Brain bleed breakthrough? continuous drug infusion may speed recovery
Disease control By invitation onlyThe study aims to investigate the effect of continuous tPA irrigation into the ventricles. Investigators believe it may be superior to the traditional every 8-hour bolus dosing and continuous isotonic solution irrigation alone. The protocol plans to analyze blood clearance and fu…
Phase 4 • Sponsor: David Dornbos • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Triple-Drug attack on stomach cancer shows promise in major trial
Disease control Recruiting nowThis is a Randomized, Double-Blind, Phase II/III Clinical Study of the Efficacy and Safety of Sintilimab Combined with Chemotherapy With or Without Ipilimumab N01 in Perioperative Treatment of Resectable Gastric/Gastroesophageal Junction Adenocarcinoma.
Phase 2/3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New combo therapy aims to shrink sinus tumors before surgery
Disease control Not yet recruitingThe main objective of this prospective study is to evaluate the effectiveness and safety of a novel neoadjuvant therapy for patients with locally advanced sinonasal carcinoma (SNC). The treatment consists of the standard TP chemotherapy regimen (docetaxel and cisplatin) combined …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a chicory root fiber supercharge immunotherapy against skin cancer?
Disease control Recruiting nowPrevious research has shown that a higher fiber intake may have a beneficial effect on the intestinal health and improve the effectiveness of immunotherapy, but this is not certain. The objective of this double-blinded randomized clinical trial is to analyze, whether increased di…
Phase 2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat stomach cancers
Disease control Not yet recruitingThis is a phase 2 multicenter study that will evaluate the safety and efficacy of sacituzumab tirumotecan (Sac-TMT) plus fruquintinib for the treatment of participants with locally advanced or metastatic gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma who have faile…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New study aims to slash cervical cancer deaths in HIV-positive women
Knowledge-focused Not yet recruitingBackground In sub-Saharan Africa (SSA), human papillomavirus (HPV) and HIV create a dual burden of disease that causes significant morbidity and mortality in the form of cervical cancer (CC). Women living with HIV (WLWH) have a six-fold higher risk of developing precancerous lesi…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC